fbpx

Side effects of drugs for glaucoma

Prostaglandin analogues, drugs which lower intraocular pressure, are often prescribed to people with glaucoma. However, a recent study found that they are not harmless.

 

It was already known that prostaglandin analogues (PGAs) could produce certain side effects, such as blurred vision, dryness or changes in eye colour. A new study, recently published in PLOS ONE, describes other side effects, namely the loss of periorbital fat in the upper and lower lid and the presence of ptosis (the drooping of an organ due to slackening of the muscles or ligaments that support it). Ptosis of the upper lid could aggravate visual field loss.

 

The researchers studied 343 patients over 7 months in 2011. “Because PGAs are a first line of treatment for glaucoma, these results provide physicians with one reason to reconsider when they should be added in new patients, particularly those where the aim is to prevent glaucoma such as in ocular hypertension patients or glaucoma suspects,” said Dr. Louis R. Pasquale, director of the Glaucoma Service at Massachusetts Eye and Ear.

Source: http://www.sciencedaily.com/releases/2013/05/130521121505.htm

 

Featured Posts

SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read more
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read more
SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read More
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read More
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read More
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read More
SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read more
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read more
SightGlass DOT logos 2026

Studies Presented at NCC Can Reinforce Prescriber Confidence in DOT™ Spectacle Lenses for Myopia Control

Scientific Posters from SightGlass Vision Explore Efficacy with Contrast Management Across Diverse Populations, Lack of Relationship with Astigmatism

Learn More
Optometry succession planning and legacy

Succession in Optometry Planning for a Career and a Legacy

Succession planning in optometry is a professional imperative. Learn why early preparation is vital for practice owners to protect their legacy and navigate unexpected life changes.

Read more
Vision Expo new logo

Vision Expo 2026 Returns to Orlando with Innovation, Education and a 40th Anniversary Celebration

Vision Expo 2026 returns to Orlando with innovation, fashion and education, marking the show’s 40th anniversary.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris 2026 Unveils New Identity and Vision for the Global Optical Industry

SILMO Paris returns September 25–28, 2026, introducing a refreshed identity and renewed focus on innovation, smart eyewear and emerging optical industry trends.

Read more
Essilor Stellest 2.0 lenses

EssilorLuxottica Launches Essilor Stellest 2.0 Lenses in Canada

EssilorLuxottica introduces Essilor Stellest 2.0 lenses in Canada, featuring enhanced optical signal technology for myopia management in children.

Read more